Carol Gallagher is on these Sector & Stage Rankings

Carol Gallagher's Investments On Record (7)

Company	StageDateRound Size	Total Raised
Pionyr Immunotherapeutics	Series BDec 2017$62M	$62M
Metacrine	Series BDec 2017$22M	$22M
Good2Go	Seed RoundSep 2017$7M	$7M
Co-investors: Nancy Schoendorf (Mohr Davidow Ventures)
Good2Go, Inc.	Seed RoundSep 2017$7M	$7M
Co-investors: Ruby Lee (Kleiner Perkins Caufield & Byers)
Cleave Therapeutics	Series BAug 2016$26M Series AApr 2013$10M	$36M
Co-investors: Robert Garland (New Enterprise Associates)
Millendo Therapeutics	Series BJan 2016$62M	$62M